Abstract:Recent breakthroughs in stem cell biology, especially the development of induced pluripotent stem cell technique, have generated tremendous enthusiasm and efforts to explore the therapeutic potential of stem cells in regenerative medicine. Improved understanding of stem cell biology, in addition to better control of stem cell fate, is critical to realize this potential. Small molecules, targeting specific signaling pathways and/or mechanisms, have been shown to be useful chemical tools in manipulating cell fate, state and function. These small molecules are starting to play increasingly important roles in both elucidating the fundamental biology of stem cells and facilitating the development of therapeutic approaches toward regenerative medicine. Such approaches could involve cell replacement therapies using homogenous functional cells produced under chemically defined conditions in vitro and the development of small-molecule drugs that can stimulate patients’ endogenous cells to repair and regenerate. Here, we review recent progress in using small molecules to sustain pluripotency, or induce differentiation of embryonic stem cells. We also highlight small molecules that can replace transcription factors and/or enhance efficiency during somatic cell reprogramming. Recent breakthroughs in stem cell biology, especially the development of induced pluripotent stem cell technique, have generated tremendous enthusiasm and efforts to explore the therapeutic potential of stem cells in regenerative medicine. Improved understanding of stem cell biology, in addition to better control of stem cell fate, is critical to realize this potential. Small molecules, targeting specific signaling pathways and/or mechanisms, have been shown to be useful chemical tools in manipulating cell fate, state and function. These small molecules are starting to play increasingly important roles in both elucidating the fundamental biology of stem cells and facilitating the development of therapeutic approaches toward regenerative medicine. Such approaches could involve cell replacement therapies using homogenous functional cells produced under chemically defined conditions in vitro and the development of small-molecule drugs that can stimulate patients’ endogenous cells to repair and regenerate. Here, we review recent progress in using small molecules to sustain pluripotency, or induce differentiation of embryonic stem cells. We also highlight small molecules that can replace transcription factors and/or enhance efficiency during somatic cell reprogramming. Having the ability to give rise to an entire functional organism. In mammals, the fertilized egg and early embryonic cells are totipotent. Totipotent cells not only have the potential to give rise to all the cell types of the body, but also the cell types of entire extraembryonic tissues. Having the potential to give rise to all of the cell types of the body, but not the cell types that make up the extraembryonic tissues such as the placenta. Embryonic stem cells derived from the inner cell mass of pre-implantation embryo are pluripotent. Pluripotent stem cells also include germline stem cells and derivatives, epiblast stem cells (EpiSCs) derived from the late epiblast layer of post-implantation embryos, and induced pluripotent stem (iPS) cells from somatic cells. Particularly, human embryonic stem cells (or mouse EpiSCs) can differentiate into trophoblast by BMP4 treatment. Whether it is a kind of artificial potential caused by in vitro conditions is still unknown. Having the ability to develop into different cell types within the same cell lineage. For example, hematopoietic stem cells that are multipotent can give rise to all the blood cell types. A pre-implantation embryo of about 150 cells produced by cleavage of the fertilized egg. The blastocyst is a hollow sphere made up of an outer layer of cells called trophoblast (forming the placenta eventually), a fluid-filled cavity, and a cluster of cells called inner cell mass. The cluster of cells attached to the wall of the blastocyst. These cells eventually give rise to all the organs and tissues of the whole organism, but do not give rise to the extraembryonic placenta tissues. The ICM cells are used to generate embryonic stem cells. The cell population in the post-implantation embryo that develops from the inner cell mass. The epiblast represents the final embryonic founder cells with the potential to give rise to all cell types of the adult body.

Chemically induced cell plasticity enables the generation of high-fidelity embryo model

A cell state splitter and differentiation wave working-model for embryonic stem cell development and somatic cell epigenetic reprogramming.

Self-organization of embryonic stem cells into a reproducible embryo model through epigenome editing

Chemical Pretreatment Activated a Plastic State Amenable to Direct Lineage Reprogramming

Brief Report: Combined Chemical Treatment Enables Oct4-Induced Reprogramming from Mouse Embryonic Fibroblasts

Reconstitution of Human Peri-Implantation Embryogenesis with Integrated Stem Cell-Based Embryo Models

Construction of a mammalian embryo model from stem cells organized by a morphogen signalling centre

A microfluidics-based stem cell model of early post-implantation human development

Stem Cell-Based Embryo Models: En Route to a Programmable Future

Rolling back human pluripotent stem cells to an eight-cell embryo-like stage

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules*

Single-Cell RNA-Seq Reveals Dynamic Early Embryonic-like Programs During Chemical Reprogramming.

Harnessing Endogenous Transcription Factors Directly by Small Molecules for Chemically Induced Pluripotency Inception.

Rolling back of human pluripotent stem cells to an 8-cell embryo-like stage

Pluripotent Stem Cells Induced from Mouse Neural Stem Cells and Small Intestinal Epithelial Cells by Small Molecule Compounds

Controlled Modelling of Human Epiblast and Amnion Development Using Stem Cells.

Reprogramming cell fates by small molecules

Highly Efficient and Rapid Generation of Human Pluripotent Stem Cells by Chemical Reprogramming

Small Molecules That Modulate Embryonic Stem Cell Fate and Somatic Cell Reprogramming

A small-molecule approach towards the Fountain of Youth: chemically induced pluripotent stem cells

Generation of Rat and Human Induced Pluripotent Stem Cells by Combining Genetic Reprogramming and Chemical Inhibitors